An inconvenient truth: recognizing individual differences in arteriogenesis.
作者信息
Rehman Jalees
出版信息
Circ Res. 2008 May 23;102(10):1146-7. doi: 10.1161/CIRCRESAHA.108.177311.
Abstract
摘要
相似文献
1
An inconvenient truth: recognizing individual differences in arteriogenesis.
Circ Res. 2008 May 23;102(10):1146-7. doi: 10.1161/CIRCRESAHA.108.177311.
2
Interferon-beta signaling is enhanced in patients with insufficient coronary collateral artery development and inhibits arteriogenesis in mice.
Circ Res. 2008 May 23;102(10):1286-94. doi: 10.1161/CIRCRESAHA.108.171827. Epub 2008 Apr 17.
3
Assessment of the effect of external counterpulsation on myocardial adaptive arteriogenesis by invasive functional measurements--design of the arteriogenesis network trial 2.
Int J Cardiol. 2010 Dec 3;145(3):432-7. doi: 10.1016/j.ijcard.2009.05.050. Epub 2009 Jun 17.
4
Therapeutic approaches in the stimulation of the coronary collateral circulation.
Curr Cardiol Rev. 2014 Feb;10(1):65-72. doi: 10.2174/1573403x113099990027.
5
Coronary collaterals--insights in molecular determinants and prognostic relevance.
Int J Cardiol. 2007 Mar 20;116(2):139-43. doi: 10.1016/j.ijcard.2006.04.039. Epub 2006 Jul 10.
6
Exercise Training as a Mediator for Enhancing Coronary Collateral Circulation: A Review of the Evidence.
Curr Cardiol Rev. 2020;16(3):212-220. doi: 10.2174/1573403X15666190819144336.
7
Effects of aging on the collateral circulation, and therapeutic implications.
Circulation. 2012 Jun 26;125(25):3211-9. doi: 10.1161/CIRCULATIONAHA.111.079038.
8
The future of collateral artery research.
Curr Cardiol Rev. 2014 Feb;10(1):73-86. doi: 10.2174/1573403x113099990001.
9
Salient features of the coronary collateral circulation and its clinical relevance.
Swiss Med Wkly. 2015 Jul 28;145:w14154. doi: 10.4414/smw.2015.14154. eCollection 2015.
10
The human coronary collateral circulation: development and clinical importance.
Eur Heart J. 2013 Sep;34(34):2674-82. doi: 10.1093/eurheartj/eht195. Epub 2013 Jun 5.
引用本文的文献
1
Vascular growth in health and disease.
Front Mol Neurosci. 2011 Aug 24;4:14. doi: 10.3389/fnmol.2011.00014. eCollection 2011.
2
Blocking interferon {beta} stimulates vascular smooth muscle cell proliferation and arteriogenesis.
J Biol Chem. 2010 Nov 5;285(45):34677-85. doi: 10.1074/jbc.M110.164350. Epub 2010 Aug 24.
3
Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells.
Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1675-82. doi: 10.1152/ajpheart.00665.2008. Epub 2009 Feb 27.
4
Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-alpha via the p38 mitogen-activated protein kinase pathway.
FASEB J. 2009 May;23(5):1358-65. doi: 10.1096/fj.08-110296. Epub 2009 Jan 5.
本文引用的文献
1
Interferon-beta signaling is enhanced in patients with insufficient coronary collateral artery development and inhibits arteriogenesis in mice.
Circ Res. 2008 May 23;102(10):1286-94. doi: 10.1161/CIRCRESAHA.108.171827. Epub 2008 Apr 17.
2
Molecular mechanisms of the anti-inflammatory functions of interferons.
Immunobiology. 2007;212(9-10):895-901. doi: 10.1016/j.imbio.2007.09.011. Epub 2007 Nov 8.
3
Interferons at age 50: past, current and future impact on biomedicine.
Nat Rev Drug Discov. 2007 Dec;6(12):975-90. doi: 10.1038/nrd2422.
4
Therapeutic myocardial angiogenesis.
Microvasc Res. 2007 Sep-Nov;74(2-3):159-71. doi: 10.1016/j.mvr.2007.08.005. Epub 2007 Sep 7.
5
Arteriogenesis: basic mechanisms and therapeutic stimulation.
Eur J Clin Invest. 2007 Oct;37(10):755-66. doi: 10.1111/j.1365-2362.2007.01861.x. Epub 2007 Aug 30.
6
Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis.
Arch Intern Med. 2007 May 28;167(10):989-97. doi: 10.1001/archinte.167.10.989.
7
Interferon: cellular executioner or white knight?
Curr Med Chem. 2007;14(12):1279-89. doi: 10.2174/092986707780597907.
8
The aspirin resistance controversy: clinical entity or platelet heterogeneity?
Circulation. 2006 Jun 27;113(25):2865-7. doi: 10.1161/CIRCULATIONAHA.106.635847.
9
Janus phenomenon: the interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis.
Circulation. 2004 Jun 15;109(23):2826-31. doi: 10.1161/01.CIR.0000132468.82942.F5.
10
Moving towards individualized medicine with pharmacogenomics.
Nature. 2004 May 27;429(6990):464-8. doi: 10.1038/nature02626.
Zotero 插件